KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March.

The letter was hand delivered by KidneyCan’s President, Bryan Lewis to the various leadership offices on Monday, March 11, 2019. Our Appropriations letter was co-signed by 10 other advocacy organizations asking for increased DoD funding specifically dedicated to kidney cancer research.  The DoD funding supports the Kidney Cancer Research Program (KCRP) and the ask was $30 million for fiscal year 2020.

Background:

In 2017, the kidney cancer community received the exciting news that it would be receiving first-ever dedicated funding from the DOD of $10 million.  Subsequently, the Kidney Cancer Research Program (KCRP) was formed and is administrated through the  Congressionally Directed Medical Research Program (CDMRP). This program funds ‘high risk-high reward’ kidney cancer research grants.

The inaugural program garnered more than 200 applications that resulted in 22 funded grant projects. See funded grants here.

Through our continued advocacy efforts in Washington, DC, we were able to increase the funding for the KCRP to $15 million in FY’18.   We then increased again to $20 million in FY’19.

The inaugural program was an overwhelming success and much excitement was created throughout the kidney cancer community.

We will report back to you in the months ahead with the outcome of this Congressional Appropriations request.

Please consider joining us in advocating in Washington, DC by contacting us here.

Our organization relies on funding from the general public to directly support our legislative efforts.

Please consider donating today.

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS
LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...